Catalent expects IPO to be priced between $19-$22/shr-Reuters


(Reuters) – Catalent Inc, controlled by Blackstone Group LP, said it expects its initial public offering to be priced between $19 and $22 per share, valuing the health technology company at about $2.57 billion at the top end.

Catalent’s IPO of 42.5 million shares is expected to raise about $935 million at the top end of the expected price range.

The company provides advanced delivery technologies for drugs, biologics and consumer health products.